WCG Clinical, Inc.

WCGC

US92941R1095

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

Nov. 12	Wcg Introduces Breakthrough Analytics to Optimize and Accelerate Clinical Trial Outcomes	CI
25-09-15	WCG Announces the Launch of WCG ClinSphere E eReview Manager	CI

WCG Clinical, Inc. has withdrawn its IPO in the amount of $765 million.

Published on 10/13/2021 at 12:00 am EDT

S&P Capital IQ

WCG CLINICAL, INC.

-.--%

WCG Clinical, Inc. has withdrawn its IPO in the amount of $765 million.

Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 45,000,000
PriceRange: $15 to $17

Latest news about WCG Clinical, Inc.

Nov. 12	Wcg Introduces Breakthrough Analytics to Optimize and Accelerate Clinical Trial Outcomes	CI
25-09-15	WCG Announces the Launch of WCG ClinSphere E eReview Manager	CI
25-08-25	WCG Reduces Clinical Trial Protocol Deviation by 35-50% with the Launch of Total Training, the First Comprehensive Solution for Improved Site Readiness, Engagement, and Compliance	CI
25-05-05	EResearchTechnology, Inc. completed the acquisition of eCOA business of WCG Clinical, Inc.	CI
25-04-03	WCG Announces Research Resilience Solutions to Navigate Institutional Budget Constraints	CI
25-03-09	EResearchTechnology, Inc. entered into a definitive agreement to acquire eCOA business of WCG Clinical, Inc.	CI
25-01-27	WCG Launches ClinSphere? Total Enrollment: An All-New Participant Recruitment and Retention SaaS Solution for Clinical Trials	CI
24-08-04	WCG Clinical, Inc. acquired Educational Measures, LLC.	CI
21-10-13	WCG Clinical : GIC-backed clinical trial firm WCG withdraws U.S. IPO plans	RE
21-10-13	WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans	RE
21-10-13	WCG Clinical, Inc. has withdrawn its IPO in the amount of $765 million.	CI
21-07-25	WCG Clinical, Inc. acquired VeraSci for $330 million.	CI
21-07-01	WCG Clinical, Inc. has filed an IPO in the amount of $100 million.	CI
21-06-30	WCG Clinical, Inc. acquired Intrinsic Imaging LLC for $92.1 million.	CI
20-01-07	Da Vinci Purchaser Corp completed the acquisition of WCG Holding IV Inc. and WCG Market Intelligence & Insights Inc. from WCG Holding IV LLC.	CI

WCG Clinical Holdings Inc is a United States-based company. The Company is a provider of clinical trial solutions. It is focused on providing solutions that are designed to improve clinical research. Its solutions help biopharmaceutical companies, contract research organizations, and institutions for delivery of new treatments and therapies to patients. It is organized into two segments: Ethical Review (ER) segment and Clinical Trial Solutions segment. The ER segment provides technology-enabled services that ensure clinical trials respect the rights and protect the welfare of patient participants. ER segment also provides a hosted software application to its clients. Clinical Trial Solutions (CTS) segment provides technology-enabled solutions that support the conduct of effective clinical trials, including study planning and site optimization, patient engagement, and scientific and regulatory review.

Employees

Sector

Biotechnology & Medical Research

More about the company

WCG Clinical, Inc.

Equities

WCGC

US92941R1095

Biotechnology & Medical Research

WCG Clinical, Inc. has withdrawn its IPO in the amount of $765 million.

Latest news about WCG Clinical, Inc.

Chart WCG Clinical, Inc.

Company Profile